Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID05758987

Evaluation of Blended CBT for PTSD in Regular Care: A New Format of Computer-Assisted Trauma-Focused Cognitive Behavioral Therapy: A Randomized Controlled Non-inferiority Trial

Led by Karolinska Institutet · Updated on 2025-12-26

160

Participants Needed

1

Research Sites

52 weeks

Total Duration

On this page

Sponsors

K

Karolinska Institutet

Lead Sponsor

C

Capio Group

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating a new blended trauma-focused cognitive behavioral therapy (B-TF-CBT) for adults with post-traumatic stress disorder (PTSD), comparing it to the established face-to-face prolonged exposure (PE) therapy. The study aims to determine if B-TF-CBT, which combines internet-based modules with face-to-face sessions, is not less effective than PE in reducing PTSD symptoms immediately after treatment and at 6 and 12 months follow-up. This trial is conducted in outpatient clinics within the Stockholm region. Participants receive either the blended B-TF-CBT, which includes digital support and six biweekly face-to-face therapy sessions over 9-15 weeks, or the standard PE treatment delivered face-to-face by trained therapists over the same duration. Both treatments follow structured protocols, and therapists' adherence and competence are monitored through checklists and session recordings. The study collects extensive data on symptoms, treatment engagement, and any adverse events. Throughout the trial, participants will complete questionnaires assessing PTSD symptoms, depression, anxiety, insomnia, social and work functioning, and quality of life before, during, immediately after treatment, and at 6 and 12 months post-treatment. The main measure is the PTSD Checklist (PCL-5). Researchers will analyze data for symptom changes and treatment satisfaction, using statistical models to compare the two therapies. Safety, adherence, and possible concurrent treatments are also tracked for up to a year after treatment.

CONDITIONS

Brief Title

Blended Treatment för PTSD: A New Format of Computer-Assisted Trauma-Focused Cognitive Behavioral Therapy

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • PTSD according to Diagnostic and Statistical Manual of mental disorders 5 as primary problem
  • 18 years or older
  • Basic knowledge of speaking and writing Swedish
  • No other psychological treatment at the same time
  • No ongoing threats or violence
  • If on antidepressant medication, stable dose for at least 6 weeks before starting treatment
  • Have access to the internet and a computer
  • Willingness and ability to participate after receiving study information
Not Eligible

You will not qualify if you...

  • Other diagnosis or problem is assessed as primary to PTSD
  • Moderate to severe suicidal risk
  • PTSD from childhood trauma that the person cannot remember

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - 9 to 15 weeks

Participants receive trauma-focused cognitive behavioral therapy either through a blended format combining internet-based modules with face-to-face sessions or through a standard face-to-face prolonged exposure therapy.

6 biweekly face-to-face sessions for blended treatment or regular face-to-face sessions over 9 to 15 weeks for prolonged exposure

Follow-up

Duration - 12 months post treatment

Participants complete outcome assessments to evaluate symptoms of PTSD, depression, anxiety, sleep, quality of life, and other measures at multiple time points following treatment.

Assessments at immediately post-treatment, 6 months, and 12 months post treatment

Trial Site Locations

Total: 1 location

1

Karolinska Institutet

Stockholm, Sweden

Actively Recruiting

Loading map...

Research Team

S

Sigrid Salomonsson, PhD

J

Johan Lundin, PhD student

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here